Alzheimer's Disease
From Proteopedia
(Difference between revisions)
| Line 48: | Line 48: | ||
**[[Glutamate receptor (GluA2)]] | **[[Glutamate receptor (GluA2)]] | ||
**[[Molecular_Playground/Glutamate_Receptor|Glutamate Receptor for Molecular Playground display]] | **[[Molecular_Playground/Glutamate_Receptor|Glutamate Receptor for Molecular Playground display]] | ||
| + | **[[Memantine]] | ||
*[[Human APP]] | *[[Human APP]] | ||
}} | }} | ||
Current revision
Alzheimer's Disease, is the most common form of dementia, especially in individuals over 65 years old. It is predicted to affect 1 in 85 people by 2050.
Articles in Proteopedia concerning Alzheimer's Disease include:
To view Alzheimer's Disease related proteins which are Structure Index entries see:
To view automatically seeded indices concerning Alzheimer's Disease See:
To View FDA Approved Treatments for Alzheimer's Disease See: Treatments
To view other Proteopedia pages about diseases & drug targets, See: Pharmaceutical Drug Targets
Proteopedia Page Contributors and Editors (what is this?)
David Canner, Alexander Berchansky, Joel L. Sussman, Jaime Prilusky, Wayne Decatur
